Cellosaurus BE-13 (CVCL_1081)

Cell line name BE-13
Synonyms BE13; Be13
Accession CVCL_1081
Resource Identification Initiative To cite this cell line use: BE-13 (RRID:CVCL_1081)
Comments Problematic cell line: Contaminated. Shown to be a Peer derivative (PubMed=12592342, PubMed=20143388).
Doubling time: ~40-60 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Derived from sampling site: Peripheral blood.
Disease Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1913 (Peer)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ

Markers:
AmelogeninX
CSF1PO12
D13S31711,14
D16S5398,13
D5S81812
D7S82010,12
TH017,8
TPOX11
vWA17,18
Web pages http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
Publications

PubMed=6331881
Galili U., Peleg A., Milner Y., Galili N.
Be13, a human T-leukemia cell line highly sensitive to dexamethasone-induced cytolysis.
Cancer Res. 44:4594-4601(1984)

PubMed=12592342; DOI=10.1038/sj.leu.2402799
Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.
False leukemia-lymphoma cell lines: an update on over 500 cell lines.
Leukemia 17:416-426(2003)

PubMed=20143388; DOI=10.1002/ijc.25242
Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.
Check your cultures! A list of cross-contaminated or misidentified cell lines.
Int. J. Cancer 127:1-8(2010)

PubMed=22675565; DOI=10.1371/journal.pone.0038463
Kalender Atak Z., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S.
High accuracy mutation detection in leukemia on a selected panel of cancer genes.
PLoS ONE 7:E38463-E38463(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-396
Cell line databases/resources Cosmic-CLP; 906763
GDSC; 906763
LINCS_LDP; LCL-1044
Ontologies CLO; CLO_0001921
Biological sample resources BioSample; SAMN03151896
Chemistry resources ChEMBL-Cells; CHEMBL3308184
ChEMBL-Targets; CHEMBL2366303
Gene expression databases GEO; GSM1669613
Polymorphism and mutation databases Cosmic; 906763
Cosmic; 1115589
Cosmic; 1151773
Cosmic; 1330495
Cosmic; 1760518
Cosmic; 2165705
Cosmic; 2602909